Cargando…

Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes

Polysaccharides are the most abundant polymers in nature. They exhibit robust biocompatibility, reliable non-toxicity, and biodegradable character; thus, they are employed in multiple biomedical applications. The presence of chemically accessible functional groups on the backbone of biopolymers (ami...

Descripción completa

Detalles Bibliográficos
Autores principales: Młynek, Mateusz, Trzciński, Jakub Waldemar, Ciach, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215857/
https://www.ncbi.nlm.nih.gov/pubmed/37238978
http://dx.doi.org/10.3390/biomedicines11051307
_version_ 1785048162702983168
author Młynek, Mateusz
Trzciński, Jakub Waldemar
Ciach, Tomasz
author_facet Młynek, Mateusz
Trzciński, Jakub Waldemar
Ciach, Tomasz
author_sort Młynek, Mateusz
collection PubMed
description Polysaccharides are the most abundant polymers in nature. They exhibit robust biocompatibility, reliable non-toxicity, and biodegradable character; thus, they are employed in multiple biomedical applications. The presence of chemically accessible functional groups on the backbone of biopolymers (amine, carboxyl, hydroxyl, etc.) makes them suitable materials for chemical modification or drug immobilisation. Among different drug delivery systems (DDSs), nanoparticles have been of great interest in scientific research in the last decades. In the following review, we want to address the issue of rational design of nanoparticle (NP)-based drug delivery systems in reference to the specificity of the medication administration route and resulting requirements. In the following sections, readers can find a comprehensive analysis of the articles published by authors with Polish affiliations in the last few years (2016–2023). The article emphasises NP administration routes and synthetic approaches, followed by in vitro and in vivo attempts toward pharmacokinetic (PK) studies. The ‘Future Prospects’ section was constructed to address the critical observations and gaps found in the screened studies, as well as to indicate good practices for polysaccharide-based nanoparticle preclinical evaluation.
format Online
Article
Text
id pubmed-10215857
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102158572023-05-27 Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes Młynek, Mateusz Trzciński, Jakub Waldemar Ciach, Tomasz Biomedicines Review Polysaccharides are the most abundant polymers in nature. They exhibit robust biocompatibility, reliable non-toxicity, and biodegradable character; thus, they are employed in multiple biomedical applications. The presence of chemically accessible functional groups on the backbone of biopolymers (amine, carboxyl, hydroxyl, etc.) makes them suitable materials for chemical modification or drug immobilisation. Among different drug delivery systems (DDSs), nanoparticles have been of great interest in scientific research in the last decades. In the following review, we want to address the issue of rational design of nanoparticle (NP)-based drug delivery systems in reference to the specificity of the medication administration route and resulting requirements. In the following sections, readers can find a comprehensive analysis of the articles published by authors with Polish affiliations in the last few years (2016–2023). The article emphasises NP administration routes and synthetic approaches, followed by in vitro and in vivo attempts toward pharmacokinetic (PK) studies. The ‘Future Prospects’ section was constructed to address the critical observations and gaps found in the screened studies, as well as to indicate good practices for polysaccharide-based nanoparticle preclinical evaluation. MDPI 2023-04-28 /pmc/articles/PMC10215857/ /pubmed/37238978 http://dx.doi.org/10.3390/biomedicines11051307 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Młynek, Mateusz
Trzciński, Jakub Waldemar
Ciach, Tomasz
Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes
title Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes
title_full Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes
title_fullStr Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes
title_full_unstemmed Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes
title_short Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes
title_sort recent advances in the polish research on polysaccharide-based nanoparticles in the context of various administration routes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215857/
https://www.ncbi.nlm.nih.gov/pubmed/37238978
http://dx.doi.org/10.3390/biomedicines11051307
work_keys_str_mv AT młynekmateusz recentadvancesinthepolishresearchonpolysaccharidebasednanoparticlesinthecontextofvariousadministrationroutes
AT trzcinskijakubwaldemar recentadvancesinthepolishresearchonpolysaccharidebasednanoparticlesinthecontextofvariousadministrationroutes
AT ciachtomasz recentadvancesinthepolishresearchonpolysaccharidebasednanoparticlesinthecontextofvariousadministrationroutes